Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4

January 28, 2016Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.

Post navigation

← FDA approves first drug to show survival benefit in liposarcoma Lucy’s Weight Loss System Issues Voluntary Nationwide Recall of Pink Bikini and Shorts on The Beach Dietary Supplements Due To Possible Undeclared Active Pharmaceutical Ingredient →
Proudly powered by WordPress